A Phase II Study of Maintenance With Azacitidine in MDS Patients

This study has been terminated.
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Groupe Francophone des Myelodysplasies
ClinicalTrials.gov Identifier:
NCT00446303
First received: March 9, 2007
Last updated: January 18, 2012
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)